Skip to Main Content

Paper Details

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Pediatr Blood Cancer
53
2016
Author NameAffiliation
Samuel L VolchenboumUniversity of Chicago Comprehensive Cancer Center
Samuel L VolchenboumUniversity of Chicago Comprehensive Cancer Center
Susan L CohnUniversity of Chicago Comprehensive Cancer Center
John M MarisChildren's Hospital of Philadelphia
John M MarisChildren's Hospital of Philadelphia
Charles Patrick ReynoldsCancer Center and Departments of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center School of Medicine
  • 1 - 6

Datasets

Release 1.2